Pharmaceuticals NY $100K – $500K Reviewed

Neuraceq radioactive diagnostic agent

State University of New York (

Albany, NY

radioactive diagnostic agent Neuraceq florbetaben PET imaging tracer Alzheimer's diagnosis $100K – $500K

Posted May 15, 2026

Description

The State University of New York is seeking bids for Neuraceq, a radioactive diagnostic agent used in medical imaging, categorized under Medical & Health Care procurement. This bid targets suppliers of radiopharmaceuticals and specialized medical products capable of providing this FDA-approved agent for detecting amyloid plaques in Alzheimer's disease diagnostics. Potential bidders include pharmaceutical distributors, radiopharmacy providers, and healthcare supply companies with expertise in nuclear medicine agents.

A strong match for healthcare vendors

Curated for medical & healthcare suppliers

Why we classified this as medical

The title explicitly names 'Neuraceq radioactive diagnostic agent,' which is a pharmaceutical radiotracer used for PET imaging in diagnosing Alzheimer's disease. The description confirms it as a 'Medical & Health Care' category item procured by a State University of New York, likely for medical research or clinical use.

View Original Source

Save for Later

Send to Pipeline

Closing date unconfirmed

This opportunity came through without a closing date. As a safeguard we're showing a tentative estimate of May 22, 2026 (about a week out) — treat it as a placeholder, not a real deadline.

Please confirm the actual deadline on the original source before you rely on it.

Check the source